BioCentury
ARTICLE | Clinical News

Axxess drug eluting stent regulatory update

August 9, 2010 7:00 AM UTC

Devax received CE Mark approval in the EU for its Axxess biolimus A9-eluting stent to treat coronary bifurcations. Devax has rights to biolimus A9 from Biosensors International Group Ltd. (SGX:B20, S...